The epithelial-mesenchymal transition generates cells with properties of stem cells SA Mani, W Guo, MJ Liao, EN Eaton, A Ayyanan, AY Zhou, M Brooks, ... Cell 133 (4), 704-715, 2008 | 9984 | 2008 |
Identification of molecular apocrine breast tumours by microarray analysis P Farmer, H Bonnefoi, V Becette, M Tubiana-Hulin, P Fumoleau, ... Breast Cancer Research 7, 1-1, 2005 | 971 | 2005 |
The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells A Cicalese, G Bonizzi, CE Pasi, M Faretta, S Ronzoni, B Giulini, C Brisken, ... Cell 138 (6), 1083-1095, 2009 | 842 | 2009 |
Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling C Brisken, A Heineman, T Chavarria, B Elenbaas, J Tan, SK Dey, ... Genes & development 14 (6), 650-654, 2000 | 632 | 2000 |
A paracrine role for the epithelial progesterone receptor in mammary gland development C Brisken, S Park, T Vass, JP Lydon, BW O’Malley, RA Weinberg Proceedings of the National Academy of Sciences 95 (9), 5076-5081, 1998 | 608 | 1998 |
Hormone action in the mammary gland C Brisken, B O’Malley Cold Spring Harbor perspectives in biology 2 (12), a003178, 2010 | 576 | 2010 |
Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland S Mallepell, A Krust, P Chambon, C Brisken Proceedings of the National Academy of Sciences 103 (7), 2196-2201, 2006 | 530 | 2006 |
Prolactin controls mammary gland development via direct and indirect mechanisms C Brisken, S Kaur, TE Chavarria, N Binart, RL Sutherland, RA Weinberg, ... Developmental biology 210 (1), 96-106, 1999 | 462 | 1999 |
Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism A Ayyanan, G Civenni, L Ciarloni, C Morel, N Mueller, K Lefort, ... Proceedings of the National Academy of Sciences 103 (10), 3799-3804, 2006 | 430 | 2006 |
Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis EY Chu, J Hens, T Andl, A Kairo, TP Yamaguchi, C Brisken, A Glick, ... Oxford University Press for The Company of Biologists Limited 131 (19), 4819 …, 2004 | 371 | 2004 |
Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development L Ciarloni, S Mallepell, C Brisken Proceedings of the National Academy of Sciences 104 (13), 5455-5460, 2007 | 369 | 2007 |
Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland M Beleut, RD Rajaram, M Caikovski, A Ayyanan, D Germano, Y Choi, ... Proceedings of the National Academy of Sciences 107 (7), 2989-2994, 2010 | 350 | 2010 |
Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells VL Battula, KW Evans, BG Hollier, Y Shi, FC Marini, A Ayyanan, R Wang, ... Stem cells 28 (8), 1435-1445, 2010 | 320 | 2010 |
Progesterone signalling in breast cancer: a neglected hormone coming into the limelight C Brisken Nature Reviews Cancer 13 (6), 385-396, 2013 | 305 | 2013 |
p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation V Devgan, C Mammucari, SE Millar, C Brisken, GP Dotto Genes & development 19 (12), 1485-1495, 2005 | 262 | 2005 |
Patient-derived xenograft (PDX) models in basic and translational breast cancer research LE Dobrolecki, SD Airhart, DG Alferez, S Aparicio, F Behbod, ... Cancer and Metastasis Reviews 35, 547-573, 2016 | 252 | 2016 |
Hormonal control of alveolar development and its implications for breast carcinogenesis C Brisken Journal of mammary gland biology and neoplasia 7, 39-48, 2002 | 214 | 2002 |
Progesterone/RANKL is a major regulatory axis in the human breast T Tanos, G Sflomos, PC Echeverria, A Ayyanan, M Gutierrez, JF Delaloye, ... Science translational medicine 5 (182), 182ra55-182ra55, 2013 | 212 | 2013 |
IGF-2 is a mediator of prolactin-induced morphogenesis in the breast C Brisken, A Ayyannan, C Nguyen, A Heineman, F Reinhardt, T Jan, ... Developmental cell 3 (6), 877-887, 2002 | 212 | 2002 |
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation MG Procopio, C Laszlo, D Al Labban, DE Kim, P Bordignon, SH Jo, ... Nature cell biology 17 (9), 1193-1204, 2015 | 210 | 2015 |